• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗恩病的治疗方法:临床进展

THERAPIES FOR CROHN'S DISEASE: a clinical update.

作者信息

Sobrado Carlos Walter, Leal Raquel Franco, Sobrado Lucas Faraco

机构信息

Disciplina de Coloproctologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (FMUSP), Brasil.

Departamento de Cirurgia, Unidade de Coloproctologia, Universidade de Campinas (UNICAMP), Brasil.

出版信息

Arq Gastroenterol. 2016 Jul-Sep;53(3):206-11. doi: 10.1590/S0004-28032016000300016.

DOI:10.1590/S0004-28032016000300016
PMID:27438429
Abstract

The main objectives of clinical therapy in Crohn's disease are clinical and endoscopic remission without the use of corticosteroids for long periods of time, prevention of hospitalization and surgery, and improvement of quality of life. The main limitation of drug therapy is the loss of response over the long term, which makes incorporation of new drugs to the therapeutic arsenal necessary. This review analyses the main drugs currently used in clinical treatment of Crohn's disease.

摘要

克罗恩病临床治疗的主要目标是实现临床和内镜缓解,且无需长期使用皮质类固醇,预防住院和手术,并提高生活质量。药物治疗的主要局限性在于长期疗效丧失,这使得有必要在治疗手段中加入新药。本综述分析了目前用于克罗恩病临床治疗的主要药物。

相似文献

1
THERAPIES FOR CROHN'S DISEASE: a clinical update.克罗恩病的治疗方法:临床进展
Arq Gastroenterol. 2016 Jul-Sep;53(3):206-11. doi: 10.1590/S0004-28032016000300016.
2
Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.溃疡性结肠炎和克罗恩病女性的分娩结局以及抗炎药物治疗的药物流行病学方面
Dan Med Bull. 2011 Dec;58(12):B4360.
3
[Treatment of Crohn's disease].[克罗恩病的治疗]
Ther Umsch. 2003 Mar;60(3):159-63. doi: 10.1024/0040-5930.60.3.159.
4
Medical management of Crohn's disease.克罗恩病的医学治疗。
Expert Opin Pharmacother. 2011 Nov;12(16):2505-25. doi: 10.1517/14656566.2011.609556.
5
Medical therapy for Crohn's disease: the state of the art.克罗恩病的药物治疗:最新进展
Surg Clin North Am. 2001 Feb;81(1):71-101, viii. doi: 10.1016/s0039-6109(05)70274-7.
6
[Moderate aplastic anemia associated with Crohn's disease during antithymocyte globulin treatment].[抗胸腺细胞球蛋白治疗期间与克罗恩病相关的中度再生障碍性贫血]
Rinsho Ketsueki. 1999 Oct;40(10):1105-9.
7
Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.环孢素、硫唑嘌呤和泼尼松龙联合治疗克罗恩病肛周瘘管
Z Gastroenterol. 1997 Aug;35(8):603-8.
8
Review article: medical treatment of active Crohn's disease.综述文章:活动性克罗恩病的医学治疗
Aliment Pharmacol Ther. 2002 Jul;16 Suppl 4:35-9. doi: 10.1046/j.1365-2036.16.s4.16.x.
9
Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.综述文章:改变克罗恩病的自然病程——支持和反对当前疗法的证据
Aliment Pharmacol Ther. 2007 Jan 1;25(1):3-12. doi: 10.1111/j.1365-2036.2006.03134.x.
10
Drug safety in Crohn's disease therapy.克罗恩病治疗中的药物安全性。
Digestion. 2007;76(2):161-8. doi: 10.1159/000111031. Epub 2008 Feb 7.

引用本文的文献

1
The therapeutic potential of mesenchymal stem cells in intestinal diseases: from mechanisms to clinical translation.间充质干细胞在肠道疾病中的治疗潜力:从机制到临床转化
Stem Cell Res Ther. 2025 Jul 21;16(1):393. doi: 10.1186/s13287-025-04523-y.
2
The resolvin D2 and omega-3 polyunsaturated fatty acid as a new possible therapeutic approach for inflammatory bowel diseases.解析素 D2 和 ω-3 多不饱和脂肪酸作为炎症性肠病的一种新的可能治疗方法。
Sci Rep. 2024 Nov 20;14(1):28698. doi: 10.1038/s41598-024-80051-8.
3
Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review.
植物化学物质作为炎症性肠病中肠纤维化的有前途的治疗方法:批判性评价。
Nutrients. 2024 Oct 25;16(21):3633. doi: 10.3390/nu16213633.
4
Resolution of Laryngeal Ulceration with Prednisolone Therapy in a Patient with Crohn's Disease.泼尼松龙治疗克罗恩病患者喉溃疡的疗效。
Intern Med. 2023 Jul 15;62(14):2071-2075. doi: 10.2169/internalmedicine.0422-22. Epub 2022 Nov 30.
5
Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress.间质基质细胞治疗:免疫调节特性和临床进展。
Stem Cell Res Ther. 2020 Aug 8;11(1):345. doi: 10.1186/s13287-020-01855-9.
6
Colitis and Crohn's Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease.印度结肠炎与克罗恩病基金会关于5-氨基水杨酸在炎症性肠病中应用的共识声明
Intest Res. 2020 Oct;18(4):355-378. doi: 10.5217/ir.2019.09176. Epub 2020 Jul 13.
7
Total flavone of suppresses epithelial-mesenchymal transition interfering transforming growth factor-β1 signaling in Crohn's disease intestinal fibrosis.总黄酮通过抑制转化生长因子-β1 信号通路抑制克罗恩病肠纤维化的上皮间质转化。
World J Gastroenterol. 2018 Aug 14;24(30):3414-3425. doi: 10.3748/wjg.v24.i30.3414.
8
Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress.黄连素通过改善肠道屏障功能、减轻炎症和氧化应激来缓解葡聚糖硫酸钠诱导的结肠炎。
Exp Ther Med. 2017 Jun;13(6):3374-3382. doi: 10.3892/etm.2017.4402. Epub 2017 Apr 28.